| Excerpt |
|---|
The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) is a national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics. Data (genomics, proteomics, imaging), assays, and reagents are made available to the public as a Community Resource to accelerate cancer research and advance patient care. |
TCIA has partnered with CPTAC to host both the radiology and pathology imaging data generated by the project. The other data types will be hosted in separate databases managed by the CPTAC program. TCIA will provide links to these resources as they become publicly available.
...
Collection | Cancer Type | Location | Radiology Modalities | Radiology Total | Radiology Discovery | Pathology Total | Pathology Discovery |
| Clear Cell Carcinoma | Kidney | CR, CT, DX, MR, SR | 63 | 32 | 222 | 110 | |
| Glioblastoma Multiforme | Brain | CR, CT, DX, MR, NM, SC | 66 | 41 | 189 | 100 | |
| CPTAC-HNSCC | Head and Neck Squamous Cell Carcinoma | Head-Neck | CT, SC, MR | 64 | 63 | 112 | 112 |
| Squamous Cell Carcinoma | Lung | CR, CT, DX, NM, PT | 39 | 24 | 212 | 110 | |
| Adenocarcinoma | Lung | CT, MR, PT, CR, DX, NM | 33 | 15 | 244 | 111 | |
| CPTAC-PDA | Pancreatic Ductal Adenocarcinoma | Pancreas | CR, CT, DX, MR, PT, RF, US, XA | 98 | 76 | 168 | 150 |
| Corpus Endometrial Carcinoma | Uterus | CT, MR, PT, CR, DX | 74 | 21 | 250 | 101 |
...